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Interleukin-22 (IL-22) is central to host protection
against bacterial infections at barrier sites. Both
innate lymphoid cells (ILCs) and T cells produce
IL-22. However, the specific contributions of CD4+
T cells and their developmental origins are unclear.
We found that the enteric pathogen Citrobacter
rodentium induced sequential waves of IL-22-
producing ILCs and CD4+ T cells that were each crit-
ical to host defense during a primary infection.
Whereas IL-22 production by ILCs was strictly IL-23
dependent, development of IL-22-producing CD4+
T cells occurred via an IL-6-dependent mechanism
that was augmented by, but not dependent on,
IL-23 and was dependent on both transcription
factors T-bet andAhR. Transfer of CD4+ T cells differ-
entiated with IL-6 in the absence of TGF-b (‘‘Th22’’
cells) conferred complete protection of infected
IL-22-deficient mice whereas transferred Th17 cells
did not. These findings establish Th22 cells as an
important component of mucosal antimicrobial host
defense.
INTRODUCTION
Effective host protection is characterized by integrated
responses of innate and adaptive arms of immunity. At barrier
sites (e.g., skin, respiratory, and intestinal tracts), production of
IL-22 by both innate and adaptive lymphoid cells is important
in host defense through its actions on epithelial cells (Ouyang
et al., 2011; Wolk et al., 2010). Because expression of IL-22
and its receptor segregate between hematopoietic and nonhe-
matopoietic cells, respectively, the IL-22-IL-22R axis represents
a critical link in the integration of immunity with barrier defense
(Aujla et al., 2008; Wolk et al., 2004; Zheng et al., 2008).
Cellular sources of IL-22 are diverse. IL-22-expressing innate
lymphoid cells (ILCs) have been identified in mice and humans,Immparticularly natural killer (NK)-like cells and lymphoid tissue-
inducer (LTi) cells (Colonna, 2009; Sonnenberg et al., 2011a).
IL-22-producing ILCs express the transcription factors RORgt
and AhR and have a shared requirement for IL-23 to produce
IL-22 (Sawa et al., 2010; Takatori et al., 2009). Mice deficient
for IL-23 fail to resist infection by intestinal or pulmonary bacterial
pathogens (Aujla et al., 2008; Mangan et al., 2006; Zheng et al.,
2008). In the well-studied Citrobacter rodentium model (Higgins
et al., 1999; Mundy et al., 2005), deficiency of IL-23 is fatal
early in infection because of impaired induction of intestinal
IL-22 (Cella et al., 2009; Sonnenberg et al., 2011b; Zheng
et al., 2008). Although specific contributions of different IL-22-
producing ILCs remain to be defined, their role in early barrier
protection appears indispensable.
CD4+ T cells also produce IL-22. Originally described as
a product of Th1 cells (Gurney, 2004), Th17 cells are also an
important source of IL-22 (Liang et al., 2006; Zheng et al.,
2007). In common with ILCs, IL-22 expression by Th17 cells is
positively regulated by the transcription factors RORgt and
AhR (Schraml et al., 2009; Veldhoen et al., 2008). A subset
referred to as Th22 cells has been described in humans (Duhen
et al., 2009; Trifari et al., 2009). Human Th22 cells are character-
ized by production of IL-22 with little or no IL-17 and appear to
have a counterpart in mice based on ex vivo studies that have
shown that naive CD4+ T cells differentiated with IL-6 under
conditions of no addition of TGF-b express high IL-22 and negli-
gible IL-17 compared to conventional Th17 cells differentiated in
the presence of IL-6 plus TGF-b (Zheng et al., 2007). A similar
reciprocal pattern of IL-22 and IL-17 expression was linked to
a ‘‘pathogenic’’ subset of murine Th17 cells induced under
similar conditions (Ghoreschi et al., 2010). However, the normal
function of this cell population is not well understood.
Although ILCs are a critical source of IL-22 during mucosal
infection, less is known regarding specific contributions of
IL-22 produced by CD4+ T cells. Here, we have examined the
relative contribution of ILCs and CD4+ T cells in host protection
against the enteric bacterial pathogen Citrobacter rodentium.
We find that whereas early contribution of ILC-derived IL-22
induced by IL-23 is critical to curb bacterial loads pending devel-
opment of pathogen-induced CD4+ T cells, the latter are critical
for late host protection via an IL-6-dependent mechanism that isunity 37, 1061–1075, December 14, 2012 ª2012 Elsevier Inc. 1061
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CD4+ T cells appear to be the major producers of IL-22 in the
infected intestinal tissues, with cells differentiated in the absence
of TGF-b (referred to herein as Th22 cells) providing more potent
protection on a per cell basis than conventional Th17 cells. The
transcriptome of Th22 cells differed significantly from Th17 cells
and both AhR and T-bet were required for optimal IL-22 produc-
tion by Th22 cells and their host-protective function. These find-
ings identify Th22 cells as important contributors to mucosal
host defense and suggest overlap between the functional
programming of these cells with that of the recently described
subset of Th17 cells proposed to be key contributors to autoim-
mune disease.
RESULTS
IL-23-Independent, IL-22-Dependent Protection against
C. rodentium Infection
We previously identified an essential role for IL-23 in the protec-
tive host response against C. rodentium infection (Mangan et al.,
2006). Challenge of IL-23-deficient mice (Il23a/) with high
doses of C. rodentium (R0.5 3 109 cfu) is uniformly fatal,
whereas wild-type (WT) mice develop a transient colitis before
clearing infection. In the course of titering inocula of
C. rodentium in Il23a/mice (Figure 1A), we found that at lower
doses (0.5–1.0 3 107 cfu), >90% of mice survived. To monitor
bacterial loads, a strain of C. rodentium expressing luciferase
was used to enable real-time whole-body imaging (Wiles et al.,
2006). In contrast to Il23a/ mice infected with high-dose
C. rodentium, nearly all Il23a/ mice infected with low dose
cleared infection with similar kinetics to WT mice. This was
despite more than a log-fold higher bacterial load at the peak
of infection (Figures 1B and 1C). Thus, IL-23 is essential for
protection at high doses of C. rodentium but is dispensable at
low doses.
Blockade of IL-22 in Il23a/ mice challenged with low-dose
infectionwas uniformly fatal, whether antibodywas administered
coincident with infection (day 0) or after the peak of the innate
immune response (d5) (Figure 1D). In extension of a previous
study (Zheng et al., 2008), we found that mice deficient for global
IL-17 signaling (Il17ra/) cleared infection to high-dose chal-
lenge with similar kinetics to WT mice, albeit with significantly
higher bacterial loads over the midcourse of infection (Figure S1
available online). Thus, whereas IL-17 signaling appears to be
important in restraining bacterial growth during infection, IL-17
cytokines, including IL-17A, IL-17F, and IL-17C, are not essential
for clearance. We also found that Ifng/ mice cleared infection
with comparable kinetics and bacterial loads to WT mice (Fig-
ure S1). These results implicate an IL-23-independent, IL-22-
dependent pathway that contributes to protection against
C. rodentium.
IL-6 Is Indispensable for Development
of IL-22-Producing CD4+ T Cells
IL-23 is required for production of IL-22 by ILCs (Cella et al.,
2009; Sonnenberg et al., 2011b; Zheng et al., 2008). Whereas
published data are in agreement that IL-6 induces the develop-
ment of IL-22-producing CD4+ T cells from naive precursors in
the absence of TGF-b (Duhen et al., 2009; Rutz et al., 2011;1062 Immunity 37, 1061–1075, December 14, 2012 ª2012 Elsevier InZheng et al., 2007), disparate results concerning the role for
IL-23 to induce development of IL-22 producers in mouse and
human have been reported (Duhen et al., 2009; Zheng et al.,
2007). In view of our findings that implicated an IL-23-indepen-
dent pathway to IL-22-mediated clearance (Figure 1), we
reexamined this issue.
In agreement with previous reports (Rutz et al., 2011; Zheng
et al., 2007), IL-6 alone induced the development of CD4+
T cells that expressed high amounts of IL-22 mRNA and protein,
but not IL-17A, and optimal development of IL-22 producers was
suppressed by TGF-b in favor of Th17 cell development under
APC-free conditions (Figure S2A). Addition of IL-23 to T cells
differentiated by IL-6 alone significantly enhanced their produc-
tion of IL-22, in accord with heightened expression of the IL-23
receptor (IL-23R) induced by IL-6 or IL-6+IL-23 in the absence
of TGF-b (Figures S2A–S2C). However, IL-23 alone did not
induce the development of IL-22-producing T cells from naive
precursors (Figures S2D–S2F). Indeed, the reported ability of
IL-23 to induce development of IL-22-producing CD4+ T cells
appears to be due to production of IL-6 by splenic APCs (Zheng
et al., 2007), because IL-22 was induced by addition of IL-23
alone only under conditions of IFN-g and IL-4 neutralization
(Figures 2A–2C) and was ablated either by use of Il6/ APCs
or addition of neutralizing anti-IL-6 (Figures 2A–2C and S2D–
S2F). Thus, IL-6 is essential for the differentiation of IL-22-
producing CD4+ T cells from naive precursors, whereas IL-23
is not. Rather, actions of IL-23 to enhance IL-22 appear primarily
limited to T cells primed by IL-6 under conditions of low or absent
TGF-b cosignaling—not through its direct actions on naive
T cells. In view of similar differentiation requirements and
functional properties of these cells with those of human Th22
cells (Duhen et al., 2009), we refer to them as ‘‘Th22’’ cells, to
distinguish them from conventional Th17 cells differentiated
with TGF-b.
IL-23-Dependent Induction of IL-22 and
Proinflammatory Cytokines Predominates Early
in C. rodentium Infection
Based on the foregoing, we postulated that the innate and adap-
tive immune responses contributed sequential production of IL-
22 from ILCs and CD4+ T cells during primary infection, induced
principally by IL-23 and IL-6, respectively. To characterize the
relative contributions of IL-23 and IL-6 to the innate versus adap-
tive responses to C. rodentium infection, WT, Il6/, Il23a/,
and Il22/ mice were challenged with high-dose luminescent
C. rodentium andmonitored for survival and colonization kinetics
until immune-deficient mice began dying (Figures 3A–3C). By
day 3 postinfection (PI), Il23a/mice had the greatest bacterial
loads until beginning to succumb on day 8. Colonization kinetics
and peak bacterial loads were similar for Il6/ and Il22/mice:
both groups had greater bacterial loads than WT controls but
less than Il23a/ mice. All Il23a/ mice succumbed by day
12 PI (Figure 3C). Infected Il6/ and Il22/ mice had signifi-
cantly improved survival compared to Il23a/ mice, but the
majority still succumbed by day 14 PI. All WT mice survived
and cleared the infection by 21 days PI (Figure 1C and data
not shown).
C. rodentium infection involves the descending colon and
cecal patch in WT mice (Figure S3), sites at which the bacteriumc.
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Figure 1. IL-23-Independent, IL-22-Dependent Pathway to Protection from C. rodentium Infection
(A) Survival rates of Il23a/ mice infected with high-dose (2 3 109 cfu) or low-dose (0.5 3 107 cfu) C. rodentium (n = 4–5 mice per group). Data are from one of
three similar experiments.
(B) Serial whole-body imaging of Il23a/mice inoculated with high- or low-dose of the luminescent strain of C. rodentium (strain ICC180) by gastric gavage and
imaged at the indicated days PI.
(C) Colonization kinetics ofWT or IL23a/mice inoculated with indicated doses ofC. rodentium. Light unit counts/s directly correlate with the bacterial load (data
not shown). Data are means ± SEM. *p < 0.01, **p < 0.001.
(D) Survival rates of IL23a/ mice infected with low-dose C. rodentium and dosed i.p. with 150 mg of neutralizing IL-22 mAb or isotype control every other day
starting at day 0 or day 5. Data are representative of two or more experiments with a minimum of three to four mice per group.
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Th22 Cells in Mucosal Immunityattaches to the apical surface of the epithelium. At day 3 PI,
increased bacteria colonized the epithelium of Il23a/ mice,
although no other differences were evident between groupsImm(data not shown). However, by day 8 PI there were severe
multifocal ulcerations of the descending colon in Il23a/ mice,
with translocation of dense colonies of C. rodentium as well asunity 37, 1061–1075, December 14, 2012 ª2012 Elsevier Inc. 1063
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Figure 2. IL-6 Is Indispensable for Development of IL-22-Producing CD4+ T Cells
(A) Naive OT-II-Tg CD4+ T cells were sorted and activated by Ova peptide for 3 days with splenic APCs from Il23a/ or Il6/mice, with or without addition of the
indicated neutralizing mAbs. Recovered cells were stained for surface CD4 and intracellular IL-22 and analyzed by flow cytometry. Numbers indicate the
frequencies of IL-22+CD4+ T cells.
(B and C) Pooled frequency data from three or more independent experiments performed as in (A). Data are means ± SEM (*p < 0.05, **p < 0.01).
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Th22 Cells in Mucosal Immunitymultifocal transmural inflammation—none of which were evident
in WT mice (Figures 3D and 3E; Mangan et al., 2006). Despite
severe, multifocal injury in Il23a/ mice, the degree of mucosal
inflammation in nonulcerated areas was significantly reduced
(Figures 3D and 3E and data not shown), resulting in reduced
recoveries of T cells and other mononuclear cells from colons
of Il23a/ mice (>40% reduction versus WT).1064 Immunity 37, 1061–1075, December 14, 2012 ª2012 Elsevier InCompared to WT mice, colons of infected Il6/ and Il22/
mice had significantly increased epithelial injury and ulceration,
which was comparable in both groups, although significantly
reduced and more focal than in Il23/ mice (Figures 3D and
3E). This was associated with significantly greater numbers of
invasive bacterial colonies. Mucosal inflammation was increased
in both Il6/ and Il22/ mice compared to Il23a/ mice, asc.
Immunity
Th22 Cells in Mucosal Immunitywas crypt hyperplasia (Figure 3E). T cell recoveries were similar
in WT, Il6/, and Il22/ mice, consistent with comparable
inflammation scores. Thus, at the peak of infection (day 8),
when the adaptive immune response had become predominant,
Il6/ and Il22/ mice had similarly impaired host protection
against C. rodentium, which, although substantial, was less
severe than that of Il23/ mice. The greater severity of disease
and mortality in Il23/mice imply that there are host-protective
effects of IL-23 during the early course of infection that are not
mediated by IL-6 or IL-22 alone.
To define differences in the inflammatory response of Il23/
versus Il6/ and Il22/ mice that might contribute to the
distinct survival and bacterial clearance, production of key cyto-
kines and chemokines at the peak of the innate response was
compared (Figure 3F). Notably, IL-6 was highly attenuated in
colon explants of Il23a/ mice compared to both WT and
Il22/ mice, akin to the defect in IL-22 production in the
absence of IL-23. Significant reductions in IL-1b and TNF-a, as
well IFN-g, were associated with the loss of IL-6 production in
Il23/ mice, suggesting that multiple proinflammatory signals
downstream of IL-23 might contribute to reductions in mucosal
IL-6. Notably, marked reductions of IL-1b and TNF-a found
in colons of infected Il23a/ mice might also contribute to
reductions in IL-22, because both cytokines can enhance IL-22
induction by ILCs. Conversely, normal production of IL-1b and
TNF-a was found in the involved colonic segments of Il6/
and Il22/ mice.
Decreases in chemokines (e.g., CCL2 and CXCL1) and proin-
flammatory cytokines in Il23a/ mice probably contributed to
the more limited inflammation in the colons of these mice,
despite profound loss of barrier function (Figure 3F and data
not shown). Of the additional cytokines examined, GM-CSF
and G-CSF were the only ones that were significantly abrogated
in both Il23a/ and Il6/ mice compared to WT, with signifi-
cantly greater reductions in Il23a/ mice. Thus, IL-23, but not
IL-6, is essential for induction of key proinflammatory cytokines
and IL-22 during the early course of infection, consistent with
its indispensable role in coordination of the mucosal innate
immune response (Buonocore et al., 2010; Cella et al., 2009;
Sonnenberg et al., 2011b; Zheng et al., 2008).
IL-6-Dependent Production of IL-22 by CD4+ T Cells
Predominates Late in C. rodentium Infection
To better define the contribution of IL-6 to IL-22 expression,
kinetics of IL-22 production by mice deficient for IL-23 or IL-6
were compared to WT controls. As early as day 2 PI, reduced
IL-22 was detected in Il23a/ mice. This became significant
on day 3 and was reduced through day 8 when the infected
mice began to succumb (Figure 4A). Despite a modest, progres-
sive increase in IL-22 in Il23a/ mice, this was insufficient to
prevent bacterial dissemination and death (Figures 3A–3E).
Reduction of IL-22 was also observed in Il6/mice (Figure 4A),
albeit delayed relative to that of Il23a/ mice; it was not
significant until day 5 PI, when decreased IL-22+CD4+ T cells
were observed (Figures 4B and 4C). Of note, significant produc-
tion of IL-22 was induced by anti-CD3 as early as day 3 PI (Fig-
ure 4D), indicating the presence of IL-22+ T cells when IL-22
production by ILCs is dominant (Sonnenberg et al., 2011b;
Zheng et al., 2008).ImmBy day 8 PI, the deficit in IL-22 was significantly greater in
Il6/ than in Il23/ mice (Figure 4A). This correlated with
a more pronounced decrease in frequencies of IL-22+ T cells in
the lamina propria (LP) of Il6/ mice (Figures 4B and 4C) and
was consistent with a predominance of IL-22+CD4+ T cells rela-
tive to ILCs (CD3CD4 and CD3CD4+ cells) in WT mice
(Figures S4A and S4B). Indeed, of the total IL-22+ cells over
the first 8 days of infection, CD4+ T cells were significantly
more abundant. Further, IL-22+IL-17 (single-positive; SP)
CD4+ T cells were more frequent than IL-22+IL-17+ (DP) cells
at each time point in infected WT mice (Figure S4C), and, under
conditions of ex vivo costimulation with IL-23, SP cells ex-
pressed the highest IL-22 per cell, indicating that they were
probably the dominant source of IL-22 (Figure S4A). Accordingly,
IL-22 production in WT mice at day 8 PI was almost a log-fold
higher than at day 3 (605 pg/ml versus 74 pg/ml) (Figure 4A), indi-
cating that IL-22 contributed by CD4+ T cells surpassed that
contributed by ILCs earlier in the infection. This was consistent
with significantly more IL-22 elicited by anti-CD3 than IL-23 stim-
ulation of colonic lymphoid cells (Figure 4D), and the observation
that IL-22 production in Il23a/ mice was IL-6 dependent and
therefore of T cell origin (Figure S4D). The critical role for IL-6
in the absence of IL-23 was highlighted by uniform fatality of
low-dose C. rodentium infection in Il23a/ mice treated with
neutralizing antibody to IL-6 (Figure S4E). Note that although
the relative deficits of IL-22 produced by Il23a/ and Il6/
mice at day 8 (Figure 4A) appear more modest than might be ex-
pected from the far greater decrease in IL-22+CD4+ T cells in the
latter (Figure 4B), when normalized for the considerably reduced
numbers of T cells recruited to the colons of Il23a/ mice
(Figure 3E and data not shown), the greater deficit of IL-22 in
Il6/ mice more closely mirrored the reduction in IL-22+
T cells in these mice.
Because IL-21 has been identified as an autocrine factor
downstream of IL-6 that promotes Th17 cell development and
IL-22 expression by Th17 cells (Nurieva et al., 2007), we sought
to determine whether IL-21 is important in host protection and
the induction of CD4+ T cell-derived IL-22. Despite delayed
clearance and elevated bacterial loads between weeks 2 and 5
PI (Figures S4F and S4G) and modest reductions in mucosal
IL-22+CD4+ T cells in Il21/ mice, there was no increased
mortality compared to WT controls and treatment of these
mice with anti-IL-6 resulted in significant reductions in IL-
22+CD4+ T cells and increased mortality (Figures S4H and S4I
and data not shown). Thus, although IL-21 is required for efficient
clearance of C. rodentium, in its absence the IL-6-dependent
T cell response is sufficient to control bacterial loads and prevent
mortality.
The importance of T cell-derived IL-22 to host protection was
reflected in the marked decline of survivingWTmice treated with
anti-IL-22 after day 5 of infection (Figure 4E). Whether adminis-
tered during the onset of infection (days 0 and 3) or on days 6,
7, and 8, after the peak of the innate response, IL-22 blockade
in WT animals resulted in comparable survival kinetics to that
of Il22/ and Il6/mice (Figure 3C). Conversely, administration
of IL-22-Fc after the peak of the innate response rescued both
Il22/ and Il6/ mice (Figures 4F and 4G). Because Il6/
mice retain IL-22-producing ILCs but are deficient in IL-22-
producing T cells, IL-6-dependent induction of IL-22+CD4+unity 37, 1061–1075, December 14, 2012 ª2012 Elsevier Inc. 1065
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Figure 3. IL-23 Governs Early Protective Immunity to C. rodentium
(A) Whole-body imaging of WT, Il23a/, Il22/, and Il6/ mice inoculated with 2 3 109 cfu of luminescent strain of C. rodentium and imaged at the
indicated days PI.
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of IL-22 production by ILCs has peaked.
Reciprocal Expression of T-bet, AhR, and RORgt in Th22
versus Th17 Cells
To identify factors that might distinguish Th22 and Th17 cell
developmental programs, comparative transcriptome analysis
was performed (Figures 5A and 5B). Among 611 genes with at
least a 2-fold difference in expression between the two subsets
(Figure 5A), notable reciprocal differences were found between
transcripts encoding RORgt, RORa, and the aryl hydrocarbon
receptor (AhR) by Th17 cells and T-bet by Th22 cells (Figure 5B
and data not shown). This was in contrast to IRF4 and
BATF (Huber et al., 2008; Schraml et al., 2009), which were not
significantly different between the two populations (data not
shown). Expression differences were validated by quantitative
RT-PCR (Figure 5C and data not shown). Thus, transcripts en-
coding RORgt (Rorc) and AhR (Ahr) were increased in polarized
Th17 cells, with increasing expression differences correlating
with the dose of TGF-b, whereas T-bet (Tbx21) was increased
in polarized Th22 cells.
Differential expression of T-bet and RORgt in Th22 and Th17
cells was verified by flow cytometry, gating on the IL-22+ fraction
of each (Figure 5D). Consistent with gene expression data,
IL-22+ Th22 cells expressed T-bet, which was not detected in
IL-22+ Th17 cells; T-bet expression was modestly but reproduc-
ibly increased by IL-23. Conversely, RORgt expression by IL-22+
cells was markedly increased in Th17 polarized cells and was
reduced in Th22 polarized cells, irrespective of IL-23 addition.
Consistent with these results, IFN-g did not inhibit, but modestly
enhanced, Th22 cell development (data not shown), in contrast
to the potent inhibitory effects of IFN-g on the development of
Th17 cells (Harrington et al., 2005). In sum, these observations
establish that distinct transcription factor networks underpin
Th22 versus Th17 cell development and suggest a T-bet-depen-
dent mechanism for enhanced IL-22 expression by developing
Th22 cells. These data further suggest that induction of IL-22
expression might be differentially regulated by T-bet and AhR
in the context of the Th22 and Th17 cell pathways, respectively.
Th22Cells AreProtective againstC. rodentium Infection
via a T-bet- and AhR-Dependent Mechanism
In view of the foregoing findings, we postulated that Th22
cells were protective againstC. rodentium infection and required
T-bet for their optimal development and function. Further, we
posited that, in contrast to Th17 cells, AhRmight be dispensable
for IL-22 expression by Th22 cells. We therefore examined the
expression of Il22 transcripts from Th17 and Th22 cells gener-(B) Colonization kinetics of WT, Il23a/, Il22/, and Il6/ mice inoculated wit
*p < 0.05, **p < 0.01.
(C) Survival rates of WT, Il23a/, Il22/, and Il6/ mice inoculated with 2 3 10
(D) Histopathology of distal colonic tissues fromWT, Il23a/, Il22/, and Il6/m
left panels, 25 mm in right panels). White arrows denote individual clusters of C. ro
colonies that extend into colonic crypts and penetrate the epithelium (Il22/ and
dying colonic epithelial cells.
(E) Histopathological scoring of colons from infected WT, Il23a/, Il22/, and
Procedures. Data are means ± SEM from two or more experiments (n = 3–4 mic
(F) Multiplexed cytokine ELISA of the indicated cytokines and chemokines from su
mice collected day 3 PI (24 hr cultures). Data are means ± SEM from two or mor
Immated in vitro from WT, Tbx21/, or Ahr/ mice (Figure 6A).
Notably, deficiency of T-bet significantly compromised expres-
sion of Il22 transcripts in Th22 cells, but had no significant impact
on Il22 expression by Th17 cells (Figure 6A). However, differen-
tiation of Th17 cells in the presence of IL-23, which induced 4-
fold higher amounts of T-bet (Figure S5A), augmented their IL-22
production in a T-bet-dependentmanner (Figures S5B and S5C).
In agreement with previous reports (Veldhoen et al., 2008),
AhR was essential for Il22 induction in Th17 cells. Thus, although
Il22 transcripts were substantially lower in Th17 cells than in
Th22 cells, they were reduced to background in AhR-deficient
Th17 cells (Figure 6A). Unexpectedly, despite lower expression
of Ahr by Th22 cells (Figure 5C), AhR deficiency also significantly
reduced their expression of Il22. Reciprocal expression of T-bet
and AhR in Th22 and Th17 cells suggested that actions of T-bet
to enhance Il22 expression were unlikely due to increased
expression of Ahr downstream of T-bet. Indeed, expression
levels of Ahr were increased in T-bet-deficient Th22 cells (Fig-
ure 6B). Conversely, Tbx21 was increased in AhR-deficient
Th22 cells. Finally, c-Maf is a repressor of Il22 transcription
(Rutz et al., 2011), raising the possibility that T-bet might
suppress c-Maf as a mechanism to enhance Il22 transcription.
However, whereas Tbx21 and maf were reciprocally expressed
by Th22 and Th17 cells (Figure 5B), maf transcripts were not
affected by T-bet deficiency in either Th22 or Th17 cells (Fig-
ure 6C), indicating that IL-22-enhancing actions of T-bet were
not due to suppression of maf.
Collectively, these results indicated that optimal Il22 induction
by Th22 cells is both T-bet and AhR dependent, suggesting
cooperative actions of these factors in enhancing Il22 transcrip-
tion. To directly test this, WT and T-bet-deficient Th22 cells were
treated with the AhR antagonist CH-223191 to determine
whether the residual expression of IL-22 found in T-bet-deficient
T cells was AhR dependent (Figure 6D). Pharmacologic inhibition
of AhR in T-bet-deficient Th22 cells further reduced IL-22 to near
background levels. IL-22 produced by Th17 cells fromWT and T-
bet-deficient mice were also ablated by AhR antagonism, indi-
cating that at the high levels of expression AhR found in Th17
cells, Il22 expression is induced independently of T-bet.
To determine whether IL-22 production by T cells was T-bet
and AhR dependent in vivo, WT, Tbx21/, and Ahr/ mice
were inoculated with C. rodentium. In contrast to WT and
Tbx21/ mice, nearly all Ahr/ mice rapidly succumbed to
infection, consistent with this factor’s role in IL-22 production
by ILCs (Kiss et al., 2011). However, in the few Ahr/ mice
that survived long enough to assess the T cell response, the
frequency of IL-22+CD4+ T cells was significantly reduced, sup-
porting the in vitro findings (Figures 6A and S6 and data noth 2 3 109 cfu of luminescent strain of C. rodentium. Data are means ± SEM.
9 cfu of C. rodentium.
ice collected 8 days PI. H&E-stained sections (scale bars represent 100 mm in
dentium attached to the apical surface of the colonic epithelium (WT) or dense
Il6/) or deeply invade the necrotic mucosa (Il23a/). Black arrows denote
Il6/ mice was performed at day 8 PI as per Supplemental Experimental
e per group). *p < 0.05, **p < 0.01.
pernatants of colonic tissue homogenates fromWT, Il23a/, Il6/, and Il22/
e experiments (n = 3–4 mice per group). *p < 0.05, **p < 0.01.
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Figure 4. IL-6-Induced CD4+ T Cells Are Major Sources of Protective IL-22 Late in C. rodentium Infection
(A) WT, Il23a/, and Il6/micewere inoculatedwith 23 109 cfuC. rodentium and colonic tissues collected at the indicated days PI for assessment of production
of IL-22 in homogenate supernatants cultured for 24 hr. Data are means ± SEM (*p < 0.05, **p < 0.01).
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Th22 Cells in Mucosal Immunityshown). In contrast, the majority of Tbx21/ mice survived
infection, andwhen examined on day 8 PI were found to produce
more than 2-fold less IL-22 than WT controls (Figure 6E), and
frequencies of IL-22+CD4+ T cells in Tbx21/ mice were
reduced 3-fold (Figure 6F). Notably, although T-bet deficiency
compromised both total IL-22+ T cells and IL-22-IL-17DP T cells,
frequencies of IL-17 SP cells were not affected, consistent
with in vitro findings (Figures 6A and 6D) and T-bet-independent
IL-22 induction in conventional Th17 cells but not Th22 cells.
In accord with decreased IL-22-producing CD4+ T cells in
Tbx21/ mice, bacterial loads were significantly greater during
the adaptive phase of the response (Figure 6G). Neverthe-
less, few of the Tbx21/ mice innoculated with high-dose
C. rodentium succumbed to infection because of unimpaired
ILC responses, and bacterial loads were gradually controlled
through the development of an unimpaired, protective antibody
response in these mice (data not shown).
To bypass the contribution of ILC-derived IL-22 and more
directly examine the protective function of Th22 and Th17 cells,
transfers of different populations of polarized CD4+ T cells into
IL-22-deficient mice were performed (Figures 7A and 7B). Naive
WT CD4+ T cells were differentiated with IL-6 alone (Th22 cell
polarizing conditions), IL-23 alone, or with IL-6+TGF-b, with or
without addition of IL-23 (Th17 cell polarizing conditions) and
then transferred into C. rodentium-infected Il22/ mice after
the peak of the innate response (Figure 7A). Whereas Il22/
recipients of Th22 cells were nearly completely protected
compared to mice that received no T cells (10% versus 85%
mortality; p < 0.01), recipients of IL-23-induced CD4+ T cells
were not protected (100% mortality), in accord with their lack
of IL-22 production (Figures 2A, S2A, and S2D). In contrast to
recipients of Th22 cells, recipients of Th17 cells showed only
modest, albeit significant, improvement in mortality and survival
times whether treated with IL-23 or not.
Consistent with a requirement for T cell-derived IL-22 for
protection, transfers of Il22/ T cells polarized under Th22 cell
conditions failed to enhance survival (Figure 7B). Notably, recip-
ients of Th22 cells derived from either Tbx21/ or Ahr/ mice
had similarly impaired protection, consistent with important roles
for both T-bet and AhR in expression of IL-22 by Th22 cells.
Thus, Th22 cells provide greater host protection against lethal
C. rodentium infection than do Th17 cells, via an IL-22-
dependent mechanism that requires T-bet and AhR for optimal
antipathogen defense.
DISCUSSION
In this study we define an important role for Th22 cells inmucosal
defense against the enteric bacterial pathogen Citrobacter(B) Colonic LP cells of WT, Il23a/, and Il6/ mice infected with C. rodentium
expression of intracellular IL-22 and IL-17A by CD3+CD4+ gated cells. Numbers
(C) Flow cytometric frequency data for LPL isolates of WT, Il23a/, and Il6/mic
mice per group). Data are means ± SEM (*p < 0.05, **p < 0.01).
(D) IL-22 secretion by colon homogenates fromWT mice prepared on the indicate
are means ± SEM (*p < 0.05, **p < 0.01).
(E) Survival rates of C. rodentium-infected WT mice that were untreated or treate
(F) Survival rates of Il6/ mice infected with C. rodentium and treated with rIL-2
(G) Survival rates of C. rodentium-infected Il22/ mice treated with rIL-22Fc pro
All data are representative of three or more experiments with a minimum of three
Immrodentium. Whereas Th17 cells were thought previously to be
central to antibacterial protection at barrier sites, including the
intestines (Aujla et al., 2008; Mangan et al., 2006; Ouyang
et al., 2008; Sonnenberg et al., 2011a; Zheng et al., 2008), we
find that Th22 cells differentiated in an IL-6-dependent, TGF-
b-independent manner are more effective in host protection
than Th17 cells. Programming of Th22 cells for high expression
of IL-22 by IL-6 was independent of IL-23, but IL-23 enhanced
production by Th22 cells primed by IL-6. Thus, although IL-23-
induced expression of IL-22 by ILCs is indispensable for protec-
tion at high inoculating doses of this pathogen, we find that
IL-23-deficient mice are protected against infection with lower
inocula via an IL-6-dependent mechanism that is linked to devel-
opment of Th22 and Th17 cells and is independent of production
of IL-22 by ILCs. Importantly, whereas Th17 cells were strictly
dependent on AhR for expression of IL-22, Th22 cells required
coexpression of AhR and T-bet for optimal expression of IL-22,
and both transcription factors were necessary for host protec-
tion by Th22 cells.
Antipathogenic responses are characterized by integration of
the innate and adaptive arms of immunity. Recent studies have
emphasized the critical role of different populations of ILCs in
protection against C. rodentium challenge, including NK-like
cells (NK-22) and CD4+ lymphoid tissue-inducer (LTi) cells
(Colonna, 2009; Sonnenberg et al., 2011a). Whereas ILCs
provide a rapid source of IL-22 that is essential for early host
protection, we find that CD4+ T cells become the dominant
source of IL-22 in the intestinal LP where the antimicrobial
response is concentrated at the height of infection. Although
the current study does not define the relative contribution of
IL-22-producing CD4+ T cells derived from Th22 cell precursors,
Th17 cell precursors, or both, it does establish a critical role for
IL-22-producing CD4+ T cells in epithelial barrier protection as
the innate response declines. Based on greater production of
IL-22 by Th22 cells derived ex vivo, the higher frequency of
IL-22+CD4+ T cells that produce IL-22 independently of IL-17A
or IFN-g coexpression, and the superior protective function of
Th22 cells transferred into infected IL-22-deficient recipients,
we favor the view that Th22 cells are the principal contributors
of IL-22 derived from the adaptive response, although this will
require further study. Irrespective of developmental origin,
however, our findings highlight a sequential model of IL-22-
dependent bacterial clearance wherein early production of
IL-22 by ILCs gives way to production of IL-22 by CD4+ T cells
that become the dominant source of IL-22 and are required for
complete clearance of infection.
Because ILCs are strictly dependent on IL-23 for their
production of IL-22, the discovery herein that IL-23-deficient
mice survive infection by low doses of C. rodentium via anwere isolated on the indicated days PI and analyzed by flow cytometry for
indicate the frequencies of cells in each quadrant.
e generated as in (B) and pooled from three independent experiments (n = 3–4
d days PI and stimulated for 24 hr with IL-23, anti-CD3, or medium alone. Data
d with neutralizing IL-22 mAb on days 0 and 3 PI or on days 6, 7, and 8 PI.
2-Fc protein (50 mg i.p.) or vehicle alone at day 5 PI.
tein (50 mg i.p.) or vehicle alone at days 0 and 3 or days 5 and 7 PI.
to four mice per group.
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Figure 5. Th22 and Th17 Cells Are Distinguished by Reciprocal Expression of T-bet, AhR, and RORgt
(A and B) FACS-sorted naive OT-II-Tg CD4+ T cells were activated by Ova peptide in presence of CD4+ T cell-depleted splenic APCs from Il23a/ mice in the
presence of IL-6 alone (Th22 cell polarization) or IL-6+TGF-b (Th17 cell polarization). CD4+ T cells were purified bymagnetic sorting after 60 hr of culture and RNA
was isolated for microarray-based gene expression analysis. Shown is a heat map of genes with more than 4-fold expression differences between the two
populations (A) and transcriptome profiling of Th22- or Th17-polarized cells by scatterplot analysis (B).
(C) Naive CD4+ T cells isolated from C57BL/6 mice were activated by anti-CD3 and anti-CD28 in presence of IL-6 and IL-23 (Th22 cell polarization), IL-6 and the
indicated concentrations of TGF-b (Th17 cell polarization), or absence of added cytokines (Th0 cells). On day 3 the cells were analyzed by RT-PCR for Rorc,
Tbx21, and Ahr transcripts. Data are means ± SEM (*p < 0.05, **p < 0.01).
(D) Naive OT-II CD4+ T cells were simulated with Ova peptide in presence of IL-6, IL-6+IL-23, or IL-6+TGF-b and analyzed by flow cytometry for frequencies of
IL-22+CD4+ T cells on day 3 after stimulation for 4 hr with PMA/I in the presence of brefeldin A. The expression of T-bet and RORgt within the IL-22+CD4+ gates
was determined by intracellular staining (histograms).
All data are representative of two or more experiments.
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Th22 Cells in Mucosal ImmunityIL-22-dependent mechanism provoked inquiry into ILC-inde-
pendent mechanisms of pathogen clearance and led to a re-
examination of mechanisms by which IL-6 deficiency confers
increased mortality (Dann et al., 2008; Zheng et al., 2008). Given
that IL-6 is required for Th22 and Th17 cell differentiation, the
finding that CD4+ T cells become the dominant source of IL-22
concordant with the decline in bacterial load provides a basis
for the impaired survival of IL-6-deficient mice despite a lack of
significantly diminished production of IL-22 by ILCs. It was re-
ported previously that IL-6 produced by the intestinal epithelium
and macrophages conferred protection against C. rodentium
infection largely through its antiapoptotic effects on the epithe-
lium (Dann et al., 2008). Although direct actions of IL-6 on the
intestinal epithelium no doubt contribute to host protection, our
finding that delivery of IL-22-Fc conferred protection of infected
IL-6-deficient mice supports a more critical role for the effects of
IL-6 on induction on IL-22-producing T cells. This is consistent
with the remarkably similar survival, colonization kinetics, and
colonic histopathology of IL-6- and IL-22-deficient mice inocu-
lated with C. rodentium and reinforces the importance of IL-22
derived from CD4+ T cells as a critical component of the host’s
response to maintain barrier integrity.
It is notable that resistance to C. rodentium infection is more
impaired in IL-23-deficient mice than in either IL-22- or IL-6-defi-
cient mice. This implies that IL-23 exerts host-protective effects
that are independent of its actions to induce IL-22 and IL-6,
production of which in the intestinal mucosa are severely
compromised in the absence of IL-23. Thus, in addition to
directly impairing IL-22 production by ILCs and mature Th22
and Th17 cells, and perhaps indirectly impairing development
of Th22 and Th17 cells through diminished IL-6 induction, defi-
ciency of IL-23 compromises antibacterial resistance through
additional mechanisms. As noted above, IL-23-dependent
induction of IL-6 that directly promotes epithelium sparing as
well as the induction of IL-1b and TNF-a that promotes epithelial
production of antimicrobial peptides via an IL-17C-dependent
autocrine loop are probably contributory (Ramirez-Carrozzi
et al., 2011; Song et al., 2011). Further, effects of reduced local
chemokine production, as exemplified by CXCL1 (KC), among
others (data not shown), impair recruitment of innate and adap-
tive immune cells that contribute to barrier defense and eradica-
tion of the pathogen (Aujla et al., 2008; Kolls et al., 2008; Ouyang
et al., 2008). Suffice to say that in view of the range of proinflam-
matory cytokines and chemokines that are uniquely diminished
in the intestines of infected IL-23-deficient mice, the protective
effects mediated by IL-23 are probably multifactorial and will
require further study.
Whereas IL-6 was essential for the host-protective develop-
ment of IL-22-producing CD4+ T cells, IL-21 proved dispensable.
Despite a decrement in the frequency of IL-22+CD4+ T cells in
IL-21-deficient mice challenged with C. rodentium, there was
no increased mortality despite delayed pathogen clearance.
We speculate that the delayed clearance is due to an impaired
C. rodentium-specific antibody response, because systemic
and mucosal antibody production is important for host protec-
tion in this model and IL-21 deficiency results in impaired IgG
antibody responses (Bry and Brenner, 2004; Ozaki et al., 2002;
Yoshida et al., 2006). In viral infections, IL-21 has been shown
to be essential for preventing chronic infection and supportingImmoptimal antiviral antibody responses (Elsaesser et al., 2009;
Eto et al., 2011; Yi et al., 2009), and in infection with Listeria
monocytogenes, IL-21 deficiency was associated with in-
creased IL-17 production and unimpaired pathogen clearance
(Ertelt et al., 2010). Findings herein define a marginal role for
IL-21 the development of IL-22+CD4+ T cells and suggest that
its principal role in host-protective mucosal immunity might be
more related to its role in providing B cell help.
Comparative transcriptome analysis of Th22 and Th17 cells
revealed differential expression of several hundred genes,
among which were several key transcription factors. This
included reciprocal expression of transcripts encoding T-bet
and RORgt, consistent with TGF-b’s established actions in sup-
pressing Tbx21 and enhancing Rorc expression, and led to iden-
tification of T-bet as an important factor in driving high-level
expression of IL-22 and host protection by Th22 cells. In contrast
to T-bet, we found no significant difference in expression of
Eomes, a related T-box family member expressed in T cells, sug-
gesting that Eomes is unlikely to contribute to Th22 cell develop-
ment. Remarkably, despite the low levels of AhR in Th22 cells,
AhR also contributed significantly to Il22 expression in Th22 cells
such that combined loss of T-bet and AhR actions resulted in
nearly complete abrogation of Il22 expression. Regardless of
higher levels of AhR in Th17 cells, optimal IL-22 induction is
severely compromised, possibly because of TGF-b, which might
inhibit IL-22 induction by repressing T-bet and enhancing other
transcription factors, including c-Maf (Rutz et al., 2011).
Because neither T-bet nor AhR positively regulated the
expression of the other, their actions on Il22 expression appear
to be cooperative. This is in contrast to Th17 cells, which are
strictly dependent on AhR for Il22 expression (Veldhoen et al.,
2008). Thus, although our findings confirm that Th22 cells can
express Il22 independently of AhR (Rutz et al., 2011), AhR clearly
contributes to the transcriptional regulation of Il22 in both Th17
and Th22 cells and is a dominant transcription factor regulating
Il22 transcription. It should be noted that Il22 is closely linked
to the Ifng gene on chromosome 10 inmice (and to IFNG on chro-
mosome 12 in humans), suggesting that T-bet, originally
described as a critical regulator of Ifng gene expression, might
have more extended regional actions on this gene cluster. This
could offer an explanation for the original description of IL-22
as a product of Th1 cells (Gurney, 2004), which also coexpress
AhR, and has implications for Il22 expression in Th17 cells as
well, in which enhanced expression of Il22 downstream of
IL-23 is contingent upon STAT1- and/or STAT4-dependent
expression of T-bet (unpublished observations). In this regard,
it has been shown that ectopic expression of T-bet in Th17 cells
enhanced Il22 expression while suppressing expression of Il17a
and Il17f (Lazarevic et al., 2011). Given the role of IL-23-induced
T-bet in the late divergence of Th17 cells toward expression of
Ifng (Lee et al., 2009), it would appear that this mechanismmight
facilitate the development of Th22 type cells from Th17 pre-
cursor cells, a subject of current investigation.
In agreement with a recent report (Rutz et al., 2011), we
found higher expression of the AP-1 transcription factor family
member Maf (c-Maf) by Th17 cells. In view of our finding that
low expression of maf by Th22 cells was not reversed by T-bet
deficiency, the actions of T-bet to promote Il22 expression by
Th22 cells are not due to derepression of c-Maf. In addition tounity 37, 1061–1075, December 14, 2012 ª2012 Elsevier Inc. 1071
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Figure 6. IL-22 Production by Th22 Cells Is T-bet and AhR Dependent
(A–C) FACS-sorted naive CD4+ T cells (CD4+CD25CD62LhiCD44lo) from WT, Tbx21/, or Ahr/mice were activated with anti-CD3/CD28 in presence of IL-6
and IL-23 (Th22 cell polarization), IL-6 and different concentrations of TGF-b (Th17 cell polarizations), or absence of cytokines (Th0 cells). On day 3 CD4+ T cells
were restimulated with PMA/ionomycin for 6 hr and analyzed by RT-PCR for Il22 (A),Ahr and Tbx21 (B), ormaf (C) transcripts. Expression values are normalized to
Th0 cell controls. Data are means ± SEM (*p < 0.05).
(D) Naive CD4 T cells from WT or Tbx21/mice were differentiated under Th0, Th22, or Th17 cell conditions. Where indicated, the AhR antagonist CH-223191
(3 mM) was added at the initiation of cultures. IL-22 protein was quantified by ELISA from culture supernatants of T cells treated with PMA/ionomycin for 48 hr.
Data are means ± SEM (*p < 0.01).
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Figure 7. Th22 Cells Provide Superior Host
Protection to Th17 Cells
Naive CD4+ T cells from WT mice were stimulated
in vitro for 72 hr with anti-CD3+anti-CD28 with
addition of IL-6 (Th22), IL-23 (IL-23 alone), or IL-
6+TGF-b, without or with IL-23 addition (Th17 and
Th17+IL-23, respectively), prior to isolation and
transfer (A). Naive CD4+ T cells from WT, Il22/,
Tbx21/, and Ahr/ mice were similarly stimu-
lated in vitro with addition of IL-6 (WT Th22, Il22/
Th22, Tbx21/ Th22, and Ahr/ Th22, respec-
tively), prior to isolation and transfer (B). n R 5
mice per group; representative of two or more
experiments.
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Th22 Cells in Mucosal Immunitytheir decreased expression of Maf, Th22 cells also expressed
significantly lower levels ofRorc compared to Th17 cells, consis-
tent with T-bet’s actions to repress Rorc expression by direct
binding to the Rorc locus and complexing with Rorc-positive
regulator Runx1 (Lazarevic et al., 2011; Mukasa et al., 2010),
expression of which was also significantly decreased in Th22
cells (data not shown). Whether RORgt is required for Il22
expression by Th22 cells despite its relatively low expression,
akin to AhR, remains to be determined. However, these data
establish both AhR and T-bet as critical positive regulators of
Il22 expression in Th22 cells and suggest that the enhanced
expression of Il22 downstream of IL-23 in both Th22 and Th17
cells are linked to its induction of Tbx21 expression by activation
of STAT1, STAT4, or both.
Notably, the transcriptome of Th22 cells described herein is
remarkably similar to that of the ‘‘pathogenic’’ Th17 cells whose
development from naive CD4+ T cells was induced by actions
of IL-6, IL-23, and IL-1b in the absence of TGF-b (Ghoreschi
et al., 2010). These cells, referred to as Th17(23) cells, were
distinguished from conventional Th17 cells differentiated with
TGF-b, termed Th17(b) cells, by their distinct gene expression
profile and greater pathogenicity in a transfer model of experi-
mental allergic encephalomyelitis (EAE). Given their similarities
to Th17(23) cells, this begs the question of whether Th22 cells
might under certain circumstances also contribute to pathoge-
nicity in the intestine and other tissue sites. IL-22-producing
CD4+ T cells were recently reported to be pathogenic in a transfer
model of colitis that used CD45RBlo cells depleted of Treg cells
(Kamanaka et al., 2011). Given that Th22 cells were originally
described in humans (Duhen et al., 2009; Trifari et al., 2009)
and that elevations of IL-22 are found in the intestines of patients
with inflammatory bowel disease (IBD) as well as patients with
psoriasis and rheumatoid arthritis (Andoh et al., 2005; Ikeuchi
et al., 2005; Wolk et al., 2004, 2006, 2007), it will be important
to determine whether Th22 cells are contributors to pathoge-
nicity in at least some variants of human autoimmune
disease and IBD previously thought to be linked to conventional
Th17 cells.(E and F) WT and Tbx21/ mice were inoculated with C. rodentium and sacrifi
homogenates cultured ex vivo for 24 hr (E; *p < 0.05) or for analysis of expression o
quadrant indicate frequencies (CD3 and CD4 gated).
(G) Colonization kinetics of WT and Tbx21/mice infected with 23 109 luminesc
indicated days PI. Data are means ± SEM (*p < 0.05, **p < 0.01).
All data are representative of two or more experiments.
ImmEXPERIMENTAL PROCEDURES
Mice
Mice were purchased from the Jackson Laboratories and/or bred at our
facility: C57BL/6J (B6); B6.Cg-Tg(TcraTcrb)425Cbn/J (OT-II TCR transgenic);
B6.129S6-Tbx21tm1Glm/J (Tbx21/); B6.129S2-Il6tm1Kopf/J (Il6/); B6.129S7-
Ifngtm1Ts/J (Ifng/); B6.Il17ra/; B6.Il23a/ (kindly provided by Schering-
Plough Biopharma); B6.129S5-Il22tm1Lex (Il22/; kindly provided by
Genentech); B6.129S5-Il21tm1Lex (Il21/); and B6.Ahr/. All animals were
bred and maintained in accordance with institutional animal care and use
committee regulations.
Citrobacter rodentium Infection and Treatments
Citrobacter rodentium strain DBS100 (ATCC) was used for all inoculations with
the exception of experiments in which whole-body imaging was performed.
For imaging experiments, the bioluminescent C. rodentium strain ICC180
(derived from DBS100) was used (generously provided by G. Frankel and S.
Wiles, Imperial College London) (Wiles et al., 2006). Mice were inoculated
with 1–2 3 109 cfu (high dose) or 0.5 3107 cfu (low dose) in a total volume of
200 ml of PBS via gastric gavage. In vivo neutralization studies used 150 mg
per dose of IL-22 mAb (Genentech, clone 8E11), IL-6 mAb (clone MP5-
20F3), or isotype control mAb, each injected i.p. For in vivo delivery of IL-22,
hIL-22.Fc protein (Pfizer) was given i.p. at 50 mg per mouse.
Bioluminescence Imaging
Mice were anesthetized with isoflurane and placed in a supine position in
a custom-built chamber for imaging with a IVIS-100 system and Living Image
Software (Xenogen, Inc.). Baseline images were collected prior to gavage with
23 109 cfu C. rodentium strain ICC180 and whole-body images were taken at
a binning of 4 over 1 to 3 min at the indicated times during infection. Lumines-
cence emitted from the same gate in individual mice was quantified as counts
per second and pseudocolor images representing light intensity generated.
Gene Expression Analysis
Naive OT-II CD4+ T cells were sorted and activated by OVAp and T cell-
depleted splenocytes from Il23a/ mice in the presence of IL-6 alone (Th22)
or under IL-6+TGF-b (Th17). T cells were isolated after 60 hr of culture and
DNase-free RNA was isolated for microarray analysis with the Affymetrix
Mouse Gene ST 1.0 Array as previously described (Lee et al., 2009) and
analyzed as described in Supplemental Experimental Procedures.
Adoptive Transfer Experiments
Naive CD4+ T cells from pooled spleens and lymph nodes of WT, Il22/, or
Tbx21/ mice were purified by FACS sorting and differentiated for 3 daysced on day 8 PI for analysis of IL-22 production from supernatants of colon
f intracellular IL-22, IL-17A, and IFN-g by CD3+CD4+ cells (F). Numbers in each
ent C. rodentium bacterial strain and assessed by whole-body imaging on the
unity 37, 1061–1075, December 14, 2012 ª2012 Elsevier Inc. 1073
Immunity
Th22 Cells in Mucosal Immunityunder Th22 or Th17 cell conditions (see Supplemental Experimental
Procedures for details). Recovered T cells were transferred by i.p. injection
(5 3 106) cells per mouse) into recipients inoculated with C. rodentium
4 days prior to cell transfer and were analyzed for survival.
Statistical Analysis
Statistical analyses were performed with Student’s t test and p < 0.05 was
considered significant.
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE42332.
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Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
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